Benitec Biopharma Inc Share Price Today: Live Updates & Key Insights

Benitec Biopharma Inc share price today is $11.07, up -4.52%. The stock opened at $11.31 against the previous close of $11.5, with an intraday high of $11.48 and low of $10.98.

Benitec Biopharma Inc Share Price Chart

Benitec Biopharma Inc

us-stock
To Invest in {{usstockname}}
us-stock

Benitec Biopharma Inc Share Price Performance

$11.07 -0.0452(-4.52%) BNTC at 23 Mar 2026 12:16 PM Biotechnology
Lowest Today 10.98
Highest Today 11.48
Today’s Open 11.31
Prev. Close 11.5
52 Week High 17.15
52 Week Low 9.85
Day’s Range: Low 10.98 High 11.48
52-Week Range: Low 9.85 High 17.15
1 day return -
1 Week return -6.96
1 month return +3.26
3 month return -11.0
6 month return -18.52
1 year return -21.64
3 year return +229.17
5 year return -79.94
10 year return -

Benitec Biopharma Inc Institutional Holdings

Suvretta Capital Management, LLC 33.62

HHG PLC 8.48

Franklin Resources Inc 7.54

Adage Capital Partners Gp LLC 6.17

RA Capital Management, LLC 5.39

Franklin Biotechnology Discv A(acc)USD 3.50

HBM Healthcare Investments AG Ord 3.47

Vanguard Group Inc 3.42

Nantahala Capital Management, LLC 3.02

Franklin Biotechnology Discovery A 2.90

BlackRock Inc 2.75

Siren, L.L.C. 2.26

Alyeska Investment Group, L.P. 2.18

SILVERARC CAPITAL MANAGEMENT, LLC 2.13

Balyasny Asset Management LLC 1.90

Vanguard Total Stock Mkt Idx Inv 1.83

Millennium Management LLC 1.78

Geode Capital Management, LLC 1.32

Janus Henderson Hrzn Biotec E2 USD 1.26

iShares Russell 2000 ETF 1.01

Simplify Health Care ETF 0.96

Awm Investment Company Inc 0.82

Vanguard Institutional Extnd Mkt Idx Tr 0.79

Schonfeld Strategic Advisors LLC 0.76

MYDA Advisors LLC 0.65

State Street Corp 0.64

MEDICAL BioHealth EUR Acc 0.57

The Goldman Sachs Group Inc 0.57

Ameriprise Financial Inc 0.45

Fidelity Small Cap Index 0.43

Fidelity Extended Market Index 0.38

iShares Russell 2000 Growth ETF 0.37

Franklin Small Cap Growth Adv 0.22

Vanguard Russell 2000 ETF 0.21

Blackrock Extended Mkt Fund CF 0.20

Extended Equity Market Fund K 0.17

RIM Global Bioscience EUR 0.15

State St Russell Sm Cap® Indx SL Cl I 0.15

Fidelity Total Market Index 0.12

Russell Inv US Small Cap Equity Y 0.12

Benitec Biopharma Inc Market Status

Strong Buy: 4

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Benitec Biopharma Inc Fundamentals

Market Cap 376.12 M

PB Ratio 2.028

PE Ratio 0.0

Enterprise Value 192.16 M

Total Assets 99.59 M

Volume 716305

Benitec Biopharma Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:216000 0.2M, FY23:75000 0.1M, FY22:73000 0.1M, FY21:59000 0.1M

Annual Profit FY25:-396000 -0.4M, FY24:108000 0.1M, FY23:75000 0.1M, FY22:64000 0.1M, FY21:-64000 -0.1M

Annual Net worth FY25:-37917000 -37.9M, FY24:-21751000 -21.8M, FY23:-19562000 -19.6M, FY22:-18562000 -18.6M, FY21:-13781000 -13.8M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:556000 0.6M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:-120000 -0.1M, Q3/2025:-118000 -0.1M, Q2/2025:278000 0.3M, Q1/2025:-106000 -0.1M, Q4/2024:null 0.0M

Quarterly Net worth Q4/2025:-11837000 -11.8M, Q3/2025:-8965000 -9.0M, Q2/2025:-16147000 -16.1M, Q1/2025:-9354000 -9.4M, Q4/2024:-7357000 -7.4M

About Benitec Biopharma Inc & investment objective

Company Information Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Organisation Biotechnology

Employees 19

Industry Biotechnology

CEO Dr. Jerel A. Banks M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Benitec Biopharma Inc FAQs

What is the share price of Benitec Biopharma Inc today?

The current share price of Benitec Biopharma Inc is $11.07.

Can I buy Benitec Biopharma Inc shares in India?

Yes, Indian investors can buy Benitec Biopharma Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Benitec Biopharma Inc shares in India?

You can easily invest in Benitec Biopharma Inc shares from India by:

Can I buy fractional shares of Benitec Biopharma Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Benitec Biopharma Inc?

Benitec Biopharma Inc has a market cap of $376.12 M.

In which sector does Benitec Biopharma Inc belong?

Benitec Biopharma Inc operates in the Biotechnology sector.

What documents are required to invest in Benitec Biopharma Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Benitec Biopharma Inc?

The PE ratio of Benitec Biopharma Inc is N/A and the PB ratio is 2.03.